Tivantinib
According to the NCI website, tivantinib is an orally bioavailable small molecule inhibitor of c-Met with potential antineoplastic activity.
Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute
Wiki
Link to European Medicines Agency (EMEA)